CEACAM5 and metastatic malignant neoplasm in the lymph nodes: In our study, patients with gastroesophageal junction, T3/T4 penetration, lymph node metastases, CEA level ≥ 5 ng/ml and higher pre- or postoperative CTCs had lower 3-year DFS (Table 2 and Fig. 3a).